JCB, Volume 11, Number 2, 2005 Editorial Vol.11 No. 2 (2005) Editorial: Biomarkers – The kiss of death Todd Krueger   Article Vol.11 No. 2 (2005) Australian biotech companies: Navigating the maze Timothy F Herpin Australia is largely accepted as an active biotech nation and claims the sixth position globally in the industry. A recent survey of the Australian biotechnology indust Article Vol.11 No. 2 (2005) New Technology Transfer Block Exemption and Guidelines: A challenge for biotechnology Tim Gunn This paper focuses on the potential impact of the new Technology Transfer Block Exemption (TTBE) on biotechnology firms, particularly with regards to small and medium-s Article Vol.11 No. 2 (2005) Survival strategies for start-ups Dina Chaya Following recent difficult private and public equity markets, many biotech start-ups are now under considerable pressure. In this environment, start-ups are struggling Article Vol.11 No. 2 (2005) International mega-trends and growth prospects of the Finnish biotechnology industry: Recent economic research and policy implications Raine Hermans The aim of this paper is to describe recent economic growth forecasts of the Finnish biotechnology industry and provide analysis of the international and industry-speci Article Vol.11 No. 2 (2005) Growth of Indian biotech companies, in the context of the international biotechnology industry Utkarsh Palnitkar The paper discusses the evolution and growth of Indian biotech companies in recent years. It focuses on the alternative business models key players in the industry have Article Vol.11 No. 2 (2005) Determining the value of drug development candidates and technology platforms Kerstin M Bode-Greuel This paper explains a comprehensive and systematic approach to evaluate drug development projects and technology platforms, using an augmented version of net present va Article Vol.11 No. 2 (2005) Key financial trends that shape biotech business growth Alex Pavlou Datamonitor analysis has identified two key company categories currently shaping the biotech industry: the leading biotherapeutics players and the emerging biotherapeut Legal and Regulatory Updates Vol.11 No. 2 (2005) Legal and regulatory update John Wilkinson The year 2004 saw the end game of what was probably the largest and most significant patent infringement case in the English Courts of the past 10 years. Bird & Bir Legal and Regulatory Updates Vol.11 No. 2 (2005) Financial accounts reports Colin Aaronson Biacore International AB is a supplier of analytical systems that are used to generate data on protein interactions. The data are used to help understand the functional Book Review Vol.11 No. 2 (2005) Book Review: The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution Derek Burke The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution Henry I Miller, Gregory Conko Praeger Publishers, Westport CT; ISBN 0 275 97879 6; 2004; 296 pp
